Apellis Pharmaceuticals, Inc.
APLSDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492422
Apellis Pharmaceuticals, Inc. was delisted in 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.
Superinvestors holding APLS, Q1 2026
1 superinvestor reports holding Apellis Pharmaceuticals, Inc. on Form 13F, worth $42.5M in total. Weight is Apellis Pharmaceuticals, Inc.'s share of each 13F portfolio; actions compare shares with Q4 2025.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 0.6% | 1,056,000 | $42.5M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of APLS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2026
1 superinvestor holding at quarter end
Q2 2024
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q1 2024
1 superinvestor holding at quarter end
Q4 2022
0 superinvestors holding at quarter end
- Sold out
- Viking Global Investors
Q3 2022
1 superinvestor holding at quarter end
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−35.7%)